AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.470
+0.090 (3.78%)
Apr 19, 2024, 4:00 PM EDT - Market closed

AN2 Therapeutics Statistics

Total Valuation

ANTX has a market cap or net worth of $73.53 million. The enterprise value is -$33.76 million.

Market Cap 73.53M
Enterprise Value -33.76M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, after market close.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

ANTX has 29.77 million shares outstanding. The number of shares has increased by 53.85% in one year.

Shares Outstanding 29.77M
Shares Change (YoY) +53.85%
Shares Change (QoQ) -7.98%
Owned by Insiders (%) 25.94%
Owned by Institutions (%) 69.77%
Float 10.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.59
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.87, with zero debt.

Current Ratio 7.87
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -59.70% and return on invested capital (ROIC) is -55.84%.

Return on Equity (ROE) -59.70%
Return on Assets (ROA) -53.70%
Return on Capital (ROIC) -55.84%
Revenue Per Employee n/a
Profits Per Employee -$1.58M
Employee Count 41
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -70.38% in the last 52 weeks. The beta is -0.24, so ANTX's price volatility has been lower than the market average.

Beta (1Y) -0.24
52-Week Price Change -70.38%
50-Day Moving Average 3.81
200-Day Moving Average 12.29
Relative Strength Index (RSI) 26.54
Average Volume (30 Days) 478,485

Short Selling Information

The latest short interest is 272,509, so 0.92% of the outstanding shares have been sold short.

Short Interest 272,509
Short Previous Month 319,420
Short % of Shares Out 0.92%
Short % of Float 2.63%
Short Ratio (days to cover) 0.63

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -69.64M
Pretax Income -64.73M
Net Income -64.73M
EBITDA -64.68M
EBIT -64.73M
Earnings Per Share (EPS) -$2.74
Full Income Statement

Balance Sheet

The company has $107.30 million in cash and no debt, giving a net cash position of $107.30 million or $3.60 per share.

Cash & Cash Equivalents 107.30M
Total Debt n/a
Net Cash 107.30M
Net Cash Per Share $3.60
Equity / Book Value 124.70M
Book Value Per Share 4.19
Working Capital 96.46M
Full Balance Sheet

Cash Flow

Operating Cash Flow -53.29M
Capital Expenditures n/a
Free Cash Flow -53.29M
FCF Per Share -$2.26
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ANTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -53.85%
Shareholder Yield -53.85%
Earnings Yield -88.03%
FCF Yield -72.47%

Analyst Forecast

The average price target for ANTX is $6.50, which is 163.16% higher than the current price. The consensus rating is "Hold".

Price Target $6.50
Price Target Difference 163.16%
Analyst Consensus Hold
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1